Company News in the Life Science Industry

»

Reset 

Synaptive Medical Secures Health Canada Approval for Evry™

Read more ››
By: GlobenewsWire - 20 Feb 2020
Related companies:  Synaptive Medical

Smile Direct Club Stands Behind Its Chief Dentist

Read more ››
By: GlobenewsWire - 20 Feb 2020

Coherus BioSciences Announces New Employment Inducement Grants

Read more ››
By: GlobenewsWire - 20 Feb 2020
Related companies:  Coherus BioSciences, Inc.

B.C. to track origins and spread of new coronavirus with genomic technology

Read more ››
By: GlobenewsWire - 20 Feb 2020
Related companies:  Genome British Columbia

PracticeSuite Announces Launch of Affiliate Program

Read more ››
By: GlobenewsWire - 20 Feb 2020

OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020

Read more ››
By: GlobenewsWire - 20 Feb 2020
Related companies:  OPKO Health, Inc.

Zealand Pharma to attend 9th Annual SVB Leerink Global Healthcare Conference

Read more ››
By: GlobenewsWire - 20 Feb 2020
Related companies:  Zealand Pharma A/S

AB Science announces positive top-line Phase 2B/3 results for oral masitinib in progressive forms of multiple sclerosis

Read more ››
By: GlobenewsWire - 20 Feb 2020
Related companies:  AllianceBernstein L.P.

New Real-World Data Show that Abbott's FreeStyle Libre System Delivers Positive Health Outcomes for People with Type 1 and Type 2 Diabetes

MADRID, Feb. 20, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that four real-world data abstracts(i,ii,iii,iv )are being presented during the 13th Advanced Technologies & Treatments for Diabetes (ATTD) in Madrid. The new data show that users of the FreeStyle Libre system have improved... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020
Related companies:  Abbott GmbH & Co. KG

Wize Pharma Completes Bonus BioGroup Strategic Transaction

HOD HASHARON, Israel, Feb. 20, 2020 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has completed its previously announced... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020

Agenus Announces Positive Interim Data from Balstilimab and Zalifrelimab Clinical Trials in Second-Line Cervical Cancer

LEXINGTON, Mass., Feb. 20, 2020 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, today announced new clinical data from pre-planned interim analyses of balstilimab (anti-PD-1) and zalifrelimab... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020
Related companies:  Agenus Inc.

Operation Smile Joins the World Health Organization's Year-Long Effort to Celebrate 2020 as the International Year of the Nurse and the Midwife

VIRGINIA BEACH, Va., Feb. 20, 2020 /PRNewswire/ -- In support of the World Health Organization's effort, Operation Smile is excited to celebrate 2020 as the International Year of the Nurse and the Midwife. Operation Smile, an international medical charity that has provided hundreds of thousands... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020

Clinical Trial Supplies Market Worth $2.5 Billion by 2025 - Exclusive Report by MarketsandMarkets™

CHICAGO, Feb. 20, 2020 /PRNewswire/ -- According to the new market research report "Clinical Trial Supplies Market by Products & Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology,... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020

Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM | Some Market Key Players - AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Tak

The increased SCLC market size is a consequence of increasing incidence, expected entry of potential premium costs of emerging therapies, and anticipating uptake of currently approved immunotherapies across 7Major Markets that will lead to more effective therapies

Read more ››
By: PR Newswire Association LLC. - 20 Feb 2020

Anticoagulant Reversal Drugs Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2026

NEW YORK, Feb. 20, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Feb 2020

Alzheimer's Disease Therapeutics & Diagnostic Market, Forecast to 2027 - R&D Investments in Personalized Medicines is Increasing

DUBLIN, Feb. 20, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020

Newport Academy Announces Spring Line-Up Of National Conference Series On Teen Mental Health And Sustainable Healing

NASHVILLE, Tenn., Feb. 20, 2020 /PRNewswire/ -- Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020

Global Market Study on High Throughput Process Development: Increasing Adoption of High Throughput Process in Drug Development

NEW YORK, Feb. 20, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 20 Feb 2020

Make Alzheimer's A Memory

ST. LOUIS, Feb. 20, 2020 /PRNewswire/ -- Brain Cares has announced the launch of its new website - BrainCares.com. With a mission to "Make... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020

Companion Medical's InPen Diabetes Management System Receives FDA Clearance for use with Fiasp® Insulin

SAN DIEGO, Feb. 20, 2020 /PRNewswire/ -- Companion Medical, manufacturer of InPen, the first FDA-cleared smart insulin pen... Read more ››

By: PR Newswire Association LLC. - 20 Feb 2020
Related companies:  Companion Medical | Companion Fund
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies